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ACKGROUND: Regardless of the precise 
underlying molecular mechanisms, the fundamental 
deining manifestation of aging is an overall decline 
in the functional capacity of various organs to maintain 
baseline tissue homeostasis and to respond adequately to 
physiological needs under stress. There is an increasingly 
urgent need for a more complete understanding of the 
molecular pathways and biological processes underlying 
aging and age-related disorders.
CONTENT: Mitochondria constitute the most prominent 
source of adenosine triphosphate (ATP) and are implicated 
in multiple anabolic and catabolic circuitries. In addition, 
mitochondria coordinate cell-wide stress responses and 
control non-apoptotic cell death routines. The involvement 
of mitochondria in both vital and lethal processes is crucial 
for both embryonic and postembryonic development, as 
well as for the maintenance of adult tissue homeostasis. 
Age-associated telomere damage, diminution of telomere 
‘capping’ function and associated p53 activation have 
emerged as prime instigators of a functional decline of 
tissue stem cells and of mitochondrial dysfunction that 
Abstract
adversely affect renewal and bioenergetic support in diverse 
tissues. Constructing a model of how telomeres, stem cells 
and mitochondria interact with key molecules governing 
genome integrity, ‘stemness’ and metabolism provides a 
framework for how diverse factors contribute to aging and 
age-related disorders.
SUMMARY: Cellular senescence deined as an irreversible 
proliferation arrest promotes age-related decline in 
mammalian tissue homeostasis. The aging of tissue-speciic 
stem cell and progenitor cell compartments is believed to 
be central to the decline of tissue and organ integrity and 
function in the elderly. Taken into consideration that the 
overwhelming majority of intracellular reactive oxygen 
species (ROS) are of mitochondrial origin, it is reasonable 
to posit that the elevated ROS production might be caused 
by alteration in mitochondrial function during senescence. It 
is likely that mitochondria and stem cells will remain at the 
forefront of aging research also for the next decade.
KEYWORDS: aging, stem cell, mitochondrial biogenesis, 
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Introduction
Aging can be deined as ‘a progressive, generalized 
impairment of function, resulting in an increased 
vulnerability to environmental challenge and a growing 
risk of disease and death’.(1) It is generally assumed 
that accumulated damage to a variety of cellular systems 
is the underlying cause of aging.(2) There is growing 
appreciation for a more subtle role for oxidative stress in 
aging. This perspective recognizes the important role of 
reactive oxygen and nitrogen species in regulating adaptive 
responses to physiological stress (i.e. redox signaling).(3) 
One characteristic of this redox signaling is that it typically 
involves low levels of relatively short-lived oxidative stress 
under normal physiological conditions. Another important 
feature of the redox stress hypothesis in the context of aging 
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is that the signaling is dynamic and reversible. Mitochondria 
are likely targets for regulation by redox signaling, because 
they are a major source of reactive oxygen species (ROS) 
in most cells. This is supported by reports demonstrating 
that mitochondrial enzyme activities, metabolic luxes, and 
morphology are sensitive to the redox environment ex vivo 
and in cells.(4)
 To preserve genome integrity, cells have developed 
a ine-tuned machinery to counteract ROS by keeping 
them in equilibrium with reducing equivalents.(5,6) The 
maintenance of redox balance is thus critical for cells both in 
steady states and during adaptations to different conditions. 
Now, a new study by Ji, et al., demonstrates that supporting 
redox homeostasis is important also during the induction of 
pluripotency.(7)
 A diminished capacity to maintain tissue homeostasis 
is a central physiological characteristic of aging. As stem 
cells regulate tissue homeostasis, depletion of stem cell 
reserves and/or diminished stem cell function have been 
postulated to contribute to aging.(9) It has further been 
suggested that accumulated DNA damage could be a 
principal mechanism underlying age-dependent stem cell 
decline.(10,11) Multiple lines of evidence indicate that 
mitochondrial ROS also inluence homeostatic signaling 
pathways to control cell proliferation and differentiation 
and to contribute to adaptive stress signaling pathways, 
such as hypoxia.(12) Observations from premature aging 
mouse models suggest that hematopoietic progenitors are 
especially sensitive to ROS and/or redox state changes 
that promote proliferation and prevent quiescence.(13,14) 
These observations imply that ROS/redox signaling affects 
somatic stem cell function and causes progeroid symptoms 
(15) and that mitochondrial dysfunction in somatic stem 
cells may contribute to aging-related degeneration.(16)
 Increasing evidence points to telomeres and p53-
mediated DNA damage signaling being core components 
that drive the senescent or apoptotic depletion of tissue 
stem-cell reserves and age-related tissue degeneration.
(17) A speculative model that posits a connection linking 
telomere damage and p53 activation with stem-cell and 
mitochondrial dysfunction. This model offers a unifying 
explanation of how telomeres inluence the health of the 
aging organism across diverse tissues with wide-ranging 
proliferative proiles.(17)
The complexity of the aging process does not allow 
for a single all-encompassing deinition, yet decades of 
Stem Cell Hypothesis of Aging
study using diverse systems, methodologies, and model 
organisms have begun to build a consensus regarding the 
central physiological characteristics of aging. Indeed, such 
studies have shown that the process of aging is invariably 
accompanied by a diminished capacity to adequately 
maintain tissue homeostasis or to repair tissues after 
injury. When homeostatic control diminishes to the point 
at which tissue/organ integrity and function are no longer 
suficiently maintained, physiologic decline ensues, and 
aging is manifested. Consistent with this, many of the 
pathophysiological conditions aflicting the elderly, such as 
anemia, sarcopenia (loss of muscle mass), and osteoporosis, 
suggest an imbalance between cell loss and renewal. The fact 
that homeostatic maintenance and regenerative potential of 
tissues wane with age has implicated stem cell decline as a 
central player in the aging process.(18)
 Most tissues and organs contain minor populations 
of primitive stem cells and progenitor cells. These cells are 
integral irst in the developing fetus for the generation of 
tissues and organs and later in the adult for ongoing tissue 
maintenance and regeneration after injury. In general, they 
have slow turnover and reside in specialized niches, protected 
from the environment, so that only a few are activated at a 
time. Thus, stem cells are a defense against aging, replacing 
cells lost through attrition. If the rejuvenating effect of 
stem cells were perfect, senescing cells would be replaced 
indeinitely; but even in highly regenerative tissues such as 
the skin, the gut, and the hematopoietic system, age – related 
decline in function is well established.(19) Still unclear are 
the effects of aging on the stem cells themselves, which 
could contribute to inferior tissue repair.(20)
 Recent evidence supports the model that stem cells 
in several tissues are largely retained in a quiescent state 
but can be coaxed back into the cell cycle in response to 
extracellular cues, even after prolonged periods of dormancy. 
Once stimulated to divide, stem cells yield undifferentiated 
progeny, which in turn produce differentiated effector 
cells through subsequent rounds of proliferation. This 
‘hierarchical’ differentiation scheme makes sense from 
the perspective of organismal longevity — it permits 
the production of large numbers of differentiated cells 
from a single stem cell by combining subsequent steps in 
differentiation with proliferation.(21,22) Therefore, this 
approach balances the high rates of homeostatic proliferation 
that are required in tissues like the bone marrow and 
intestine with the long-term need to protect stem cells from 
mutagenic insult and carcinogenesis.(23)
 Additionally, as stem cells appear to be less 
metabolically active in their quiescent state, they may 
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be subjected to lower levels of DNA-damage-inducing 
metabolic side products such as ROS.(24) It is therefore 
reasonable to surmise that perhaps some characteristics of 
aging — once thought to be degenerative — might relect 
a decline in the regenerative capacity of resident stem 
cells across many different tissues. Self-renewal comes 
with some danger for the organism; in particular, a risk of 
malignant transformation.(25-27)
This relationship between self-renewing cells and cancer 
raises the possibility that while carrying out a beneicial, 
anti-cancer function these tumor-suppressor mechanisms 
may inadvertently contribute to aging by causing stem-
cell arrest or attrition.(23) In summary, we believe the data 
suggest that we grow old partly because our stem cells grow 
old as a result of mechanisms that suppress the development 
of cancer over a lifetime. In this regard, our self-renewing 
stem cells appear to grow old because of heritable intrinsic 
events, such as DNA damage, but also due to cell-extrinsic 
events such as alterations in their supporting niches. Anti-
cancer mechanisms such as senescence and apoptosis, which 
rely on telomere shortening and/or p5γ and p16INK4a 
activation, appear to promote aging just as their failure is 
associated with cancer.(23)
The central player in bioenergetics is the mitochondrion. 
Mitochondria produce about 90% of cellular energy, 
regulate cellular redox status, produce ROS, maintain 
Ca2+ homeostasis, synthesize and degrade high-energy 
biochemical intermediates, and regulate cell death through 
activation of the mitochondrial permeability transition pore 
(mtPTP). The mitochondrial genome consists of thousands 
of copies of the maternally inherited mitochondrial 
DNA (mtDNA) plus between 1,000 and 2,000 nuclear 
DNA (nDNA) genes. mtDNA codes for 13 oxidative 
phosphorylation (OXPHOS) polypeptides, plus the ββ 
transfer RNA (tRNA) and the 12S and 16S ribosomal RNAs 
(rRNAs) necessary for the bacteria-like mitochondrial 
protein synthesis. mtDNA polypeptides encompass seven 
of the 45 polypeptides of OXPHOS complex I (ND1, 
ND2, ND3, ND4, ND4L, ND5, and ND6), one of the 11 
polypeptides of complex III (cytochrome b), three of the 13 
polypeptides of complex IV (COI, COII, and COIII), and 
two of the approximated 17 poly-peptides of complex V 
(ATPase6 and ATPase8). Complexes I, III, and IV constitute 
the electron transport chain (ETC), which oxidizes the 
reducing equivalents (hydrogen-derived electrons) from 
food with the oxygen we breathe.(29)
 Alterations in mitochondrial structure and function 
can impair OXPHOS, which in turn can reduce energy 
production, alter cellular redox state, increase ROS 
production, deregulate Ca2+ homeostasis, and ultimately 
activate the mtPTP, leading to apoptosis. These and other 
consequences of OXPHOS perturbation can destabilize 
mtDNA. This results in progressive accumulation of 
somatic mtDNA mutations and decline of mitochondrial 
function, which accounts for aging and the delayed-onset 
and progressive course of degenerative diseases. As energy 
output declines, the most energetic tissues are preferentially 
affected, resulting in degenerative diseases of the central 
nervous system, heart, muscle, and kidney. Aberrant 
mitochondrial caloric metabolism also leads to metabolic 
deregulation, endocrine dysfunction, and symptoms such as 
diabetes, obesity, and cardiovascular disease.(29)
 In essence, mitochondria occupy a key position in 
the management of several cellular functions, including 
physiological metabolism, stress responses, and cell death. 
Intriguingly, several mitochondrial components that operate 
as cell death regulators also exert cell death–unrelated 
functions.(γ1,γβ) This might relect the evolutionary origin 
of mitochondria (which, according to the endosymbiotic 
hypothesis, have evolved from proteobacteria engulfed 
by protoeukaroytic cells) (33) or their need to centralize a 
Figure 1. A stem cell perspective on cancer and aging.(28) 
(Adapted with permission from Nature Publishing Group).
Mitochondria Control Cellular Life, 
Stress and Death
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wide array of molecular functions within a relatively small 
number of proteins (32).
 In adverse conditions, cells activate a wide array of 
mechanisms to re-establish homeostasis and to repair stress-
induced molecular damage.(34) Mitochondria are involved 
in the response of cells to a wide number of perturbations, 
including oxidative stress and pathogen invasion. In addition, 
mitochondria play a critical role during autophagy in that 
they both can be the substrate of autophagic degradation 
(mitophagy) (γ5) or can be speciically spared by the 
autophagic machinery to ensure energy production during 
stress responses (36,37). Thus, ROS constitute a normal 
side product of respiration, they are required for several 
intracellular signaling pathways (38), and are normally 
handled by an entire battery of mitochondrial, cytosolic, and 
peroxisomal antioxidant systems, including the following: 
superoxide dismutases, which catalyze the dismutation 
of superoxide anions (O
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 as well 
as other oxidized species such as organic hydroperoxides 
and peroxynitrites; thioredoxin, acting as an eficient 
reducing agent, thanks to a highly conserved CXXC motif 
that can be restored by thioredoxin reductase; glutathione, 
a tripeptide with intrinsic antioxidant properties that can be 
recycled on reduction by glutathione reductase; glutathione 
peroxidase, an enzyme that uses the reducing equivalents 






O and organic 
hydroperoxides into the corresponding alcohols; and, 
simply, thiol containing proteins, which are endowed with 
the capacity to buffer ROS by forming oxidized disulide 
bonds.(39)
 As a consequence of oxidative stress, be it endogenous 
(i.e., at tributable to self-generated ROS) or exogenous 
(i.e., attributable to extracellular ROS), mitochondria 
undergo several functional adaptations. These adaptations 
maximize the ROS-buffering capacity of mitochondria 
(and of other cellular compartments), thus allowing the 
re-establishment of homeostasis in response to mild 
oxidative stress. However, if oxidative stress persists and 
the associated molecular damage (i.e., lipid peroxidation, 
protein misfolding, mtDNA mutations) is beyond recovery, 
then mitochondria can translate such an adaptive response 
into the activation of cell death.(40) 
 Mitochondria have been shown to control (at least) 
3 distinct cell death modalities: (A) extrinsic apoptosis; 
(B) intrinsic apoptosis; and (C) regulated necrosis. 
Extrinsic apoptosis is ignited by either the ligand-induced 
oligomerization of transmembrane proteins of the death 
receptor superfamily (e.g., FAS/CD95, tumor necrosis 
factor receptor 1 (TNFR1)) (41) or when the extracellular 
concentrations of speciic trophic factors (e.g., netrin-1) fall 
below a certain threshold, leading to the transduction of 
lethal signals by the so-called dependence receptors (e.g., 
unc-5 homolog A (C. elegans) (UNC5A), deleted in colon 
cancer (DCC)).(42) On oligomerization, the cytoplasmic 
tails of death receptors drive the assembly of a multiprotein 
complex known as death-inducing signaling complex, 
eventually leading to the activation of the proapoptotic 
caspase-8-caspase-3 cascade.(43)
 Intrinsic apoptosis involves a central step of 
regulation that is mediated by mitochondria. Thus, in 
response to multiple distinct intracellular stress conditions, 
mitochondrial membranes can become permeabilized 
because of the pore-forming activity of proapoptotic 
members of the B-cell lymphoma-2 (Bcl-2) protein 
family, such as Bcl-β-associated X protein (Bax) and 
Bcl-2 homologous antagonist killer (Bak). Alternatively, 
mitochondria can lose their structural integrity after the 
so-called mitochondrial permeability transition (MPT), 
a phenomenon that is initiated at the mitochondrial inner 
membrane. In both cases, permeabilized mitochondria 
allow for the release of potentially toxic proteins into the 
cytoplasm, including cytochrome c (Cyt c). Together with 
deoxyadenosine triphosphate (dATP) and the adaptor 
protein apoptotic peptidase-associated factor 1 (APAF-
1), cytoplasmic Cyt c drives the assembly of the so-called 
apoptosome, a supramolecular complex for the activation of 
pro-caspase-9. Eventually, active caspase-9 proteolytically 
processes pro-caspase-3, resulting in the execution of 
apoptotic cell death.
 One particular instance of regulated necrosis, also 
known as necroptosis, is triggered by TNFR1 ligation when 
caspases (in particular caspase-8) are inactive (for instance 
because of the presence of the caspase inhibitor Z-VAD-
fmk). In these conditions, receptor interacting protein kinase 
(RIPK)1 and RIPK3 engage in physical and functional 
interactions with mixed lineage kinase domain-like 
(MLKL) to form a multiprotein complex called necrosome.
(44-49) The necrosome stimulates regulated necrosis at 
the mitochondrial level by inhibiting adenine nucleotide 
transferase (ANT), by exacerbating glutaminolysis (and, 
hence, inducing the overgeneration of ROS), and by 
promoting mitochondrial fragmentation.(40) Thus, with a 
relatively small number of proteins, mitochondria operate 
as highly specialized cellular sentinels that continuously 
monitor the conditions of the cell to inely adapt its metabolic 
activity, to coordinate adaptive responses to stress, and to 
decide on its inal and inexorable fate.
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Cell function relies on the constant supply of ATP and 
it is crucial that mitochondrial ATP production adapts 
to environmental and cellular challenges to maintain 
cellular function. Key molecules in sensing cellular stress 
situations seem to be the peroxisome proliferator-activated 
receptor-c coactivator (PGC)-family of transcriptional 
co-activators, which are key regulators of mitochondrial 
biogenesis. Recent work has identiied several stress-
regulated pathways that affect mitochondrial biogenesis 
through modulation of the activity of PGC-1α.(50) 
Mitochondrial biogenesis can be deined as the growth and 
division of pre-existing mitochondria. According to the 
well-accepted endosymbiotic theory, mitochondria are the 
direct descendants of an α-proteobacteria endosymbiont 
that became established in a host cell. Due to their ancient 
bacterial origin, mitochondria have their own genome and 
a capacity for autoreplication. Mitochondrial proteins are 
encoded by the nuclear and the mitochondrial genomes.(51)
 Mitochondrial biogenesis is very complex and 
requires numerous processes: besides synthesis of mtDNA 
encoded protein, biogenesis of new organellar structures 
includes synthesis and import of nuclear encoded proteins, 
assembly of the dual genetic origin derived proteins and 
mtDNA replication. Mitochondrial biogenesis relies on 
the concerted and synchronized action of these processes.
(52) Correct mitochondrial biogenesis relies on the 
spatiotemporally coordinated synthesis and import of ~1000 
proteins encoded by the nuclear genome, of which some are 
assembled with proteins encoded by mtDNA within newly 
synthesized phospholipid membranes of the inner and outer 
mitochondrial membranes. In addition, mtDNA replication 
and mitochondrial fusion and ission mechanisms must 
also be coordinated.(51) Mitochondrial biogenesis is 
triggered by environmental stresses such as exercise, cold 
exposure, caloric restriction (CR) and oxidative stress, cell 
division and renewal, and differentiation. The biogenesis of 
mitochondria is accompanied by variations in mitochondrial 
size, number, and mass.
 Mitochondrial biogenesis thus involves an intricate, 
complicated network of transcription factors nuclear 
respiratory factors (NRF)/peroxisome proliferator-activated 
receptors (PPAR)/estrogen-related receptors (ERR) that 
activate target genes encoding enzymes of fatty acid 
oxidation (FAO), OXPHOS, and anti-oxidant defence. 
PGC-1α, by co-activating, and controlling the expression 
of this network, directly links external physiological stimuli 
to the regulation of mitochondrial biogenesis and function. 
Additionally, mitochondrial biogenesis involves fusion/
ission and requires protein import and processing and 
cardiolipin biosynthesis.(53,54)
 Mitochondria in the cells of most tissues are tubular, 
and dynamic changes in morphology are driven by ission, 
fusion, and translocation.(55) The ability to undergo ission/
Figure 2. Bioenergetic paradigm for 
metabolic and degenerative diseases, 
cancer, and aging.(30) (Adapted with 
permission from American Society for 
Clinical Investigation).
Mitochondrial Biogenesis and Mitophagy
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fusion enables mitochondria to divide and helps ensure 
proper organization of the mitochondrial network during 
biogenesis. The processes of ission/fusion are controlled by 
GTPases, most of which were identiied in genetic screens 
in yeast.(56,57) Mitochondrial ission is driven by dynamin-
related proteins (DRP)1 and optic atrophy (OPA)1, while 
mitochondrial fusion is controlled by mitofusins (Mfn)-
1 and -2. Mfn are highly expressed in heart and skeletal 
muscle, and their expression is induced during myogenesis 
and physical exercise.(58,59) In addition to the control 
of the mitochondrial network, Mfn2 also stimulates the 
mitochondrial oxidation of substrates, cell respiration, 
and mitochondrial membrane potential, suggesting that 
this protein may play an important role in mitochondrial 
metabolism, and as a consequence, in energy balance.(58)
 Autophagy is a tightly regulated catabolic process 
whereby cells degrade their constituents to dispose of 
unwanted cytoplasmic elements and recycle nutrients 
for cellular remodeling.(60) The mitochondrion is an 
important actor in the life of a eukaryotic cell, but, like 
all good actors, a mitochondrion needs to exit the stage 
at the right time. Mitophagy removes mitochondria once 
they have played their part.(61) Thus, like macroscopic 
energy sources and power plants, these microscopic power 
supplies are essential but prone to release hazardous 
materials, particularly when they have been compromised 
by damage or age. Accordingly, ensuring proper elimination 
of dysfunctional mitochondria is imperative to cellular 
survival, and mitochondrial damage has been implicated 
in aging, diabetes, and neurodegenerative diseases.(62) 
To prevent cellular damage by preserving a population of 
healthy mitochondria, several quality control mechanisms 
have evolved.(61)
 Several proteins are now identiied that are critical in 
directing autophagosomes to the mitochondria, including 
autophagy-related gene (ATG)γβ, Nix, p6β, PINK1, 
and Parkin. Ubiquitination of the mitochondrion, and/
or the interaction of a mitochondrial receptor with the 
Figure 3. Conceptual illustration of the mitochondrial life cycle and the contribution of mitochondrial dynamics and mitophagy to 
quality control.(29) (Adapted with permission from American Heart Association).
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in endocrine/paracrine regulatory mechanisms, including 
activation of the renin–angiotensin–aldosterone system, 
adrenergic signaling, and an age-related dysfunction 
of growth hormone/insulin-like growth factor (IGF)-
1 signaling, also have an important role in promoting 
mitochondrial oxidative stress in the aged cardiovascular 
system.(63)
 Neurodegenerative diseases are a large group of 
disabling disorders of the nervous system, characterized 
by the relative selective death of neuronal subtypes. In 
most cases, there is overwhelming evidence of impaired 
mitochondrial function as a causative factor in these 
diseases. More recently, evidence has emerged for impaired 
mitochondrial dynamics (shape, size, ission-fusion, 
distribution, movement etc.) in neurodegenerative diseases 
such as Parkinson’s disease (PD), Huntington’s disease 
(HD), amyotrophic lateral sclerosis (ALS), and Alzheimer’s 
disease (AD).(70)
 mtDNA that encodes 13 of the 92 polypeptides of the 
OXPHOS system; the remaining structural polypeptides 
and assembly factors are encoded by nDNA. Mutations in 
either mtDNA or nDNA, resulting in OXPHOS dysfunction, 
are particularly known to affect tissues with high energy 
demands such as the central nervous system, skeletal 
muscle, and heart. Mitochondria are thought to contribute 
to aging through the accumulation of mtDNA mutations and 
net production of ROS. mtDNA mutations, mitochondrial 
abnormalities, and mitochondrial respiratory chain-deicient 
cells are also present in age-related neurodegenerative 
diseases such as PD and AD.(71-77)
 PGC-1α is a transcriptional coactivator that is a 
central inducer of mitochondrial biogenesis in cells. 
Recent work highlighted that PGC-1α can also modulate 
the composition and functions of individual mitochondria. 
Therefore, it is emerging that PGC-1α is controlling 
global oxidative metabolism by performing two types of 
remodelling:  cellular remodelling through mitochondrial 
biogenesis and organelle remodelling through alteration 
in the intrinsic properties of mitochondria. The elevated 
oxidative metabolism associated with increased PGC-
1α activity could be accompanied by an increase in ROS 
that are primarily generated by mitochondria. However, 
increasing evidence suggests that this is not the case, as 
PGC-1α is also a powerful regulator of ROS removal by 
increasing the expression of numerous ROS-detoxifying 
enzymes. Therefore, PGC-1α, by controlling both the 
induction of mitochondrial metabolism and the removal of 
its ROS by-products, would elevate oxidative metabolism 
autophagosomal protein light chain (LC)3 appear to be 
important in targeting of the autophagosome, but in each 
case the details of this recruitment remain unclear.(61)
Mitochondria play important roles in a myriad of cellular 
processes including ATP production via OXPHOS, 
biosynthetic pathways, cellular redox homeostasis, ion 
homeostasis, oxygen sensing, signaling, and regulation 
of programmed cell death. Mitochondrial dysfunction is 
central to theories of aging, because age-related changes 
of mitochondria are likely to impair a host of cellular 
physiological functions in parallel and contribute to the 
development of all common age-related diseases.(63)
 Mitochondria are highly dynamic organelles, and 
dysregulation of mitochondrial turnover is likely one of 
the intrinsic causes of mitochondrial dysfunction, which 
contributes to dysregulation of cell metabolism, oxidative 
stress, and altered signal transduction. Mitochondrial ROS 
might attack various mitochondrial constituents, causing 
mtDNA mutations and oxidative damage to respiratory 
enzymes. A defect in mitochondrial respiratory enzymes 
would increase mitochondrial production of ROS, causing 
further mitochondrial damage and dysfunction, leading 
to further decline in cellular and organ function that can 
eventually progress to death.(39)
 The molecular mechanisms underlying age-
related increases in mitochondrial oxidative stress in the 
cardiovascular system are multifaceted and likely involve 
cell-autonomous effects, including a signiicant decline 
in reduced glutathione content (64), dysregulation of 
antioxidant defense mechanisms eg, peroxynitrite-mediated 
nitration and inhibition of manganese superoxide dismutase 
(MnSOD) (65), and a dysfunctional ETC (66).
 There is a signiicant age-related increase in 
nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase activity both in heart and vasculature (67), which is 
likely to exacerbate mitochondrial oxidative stress in aging. 
In addition to the aforementioned age-related mechanisms, 
several cardiovascular risk factors, including oxidatively 
modiied lipoproteins, cigarette smoke constituents (68), 
high methionine diet and hyperhomocysteinemia, and 
diabetes (69), either directly or indirectly may increase ROS 
production in mitochondria of vascular cells and cardiac 
myocytes. Recent studies suggest that age-related changes 
Mitochondrial Dysfunction and 
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and minimize the impact of ROS on cell physiology.(78)
 Several studies also support a protective role for PGC-
1α in PD. PD is characterised by the loss of dopaminergic 
neurons in the substantia nigra and the presence of 
inclusions, referred to as Lewy bodies, which contain 
a-synuclein and ubiquitin.(79) The expression of numerous 
PGC-1α target genes, such as those of the respiratory chain, 
is decreased in Parkinson’s disease patients.(80) In support 
of this observation, Ppargc1a-null mice are more sensitive 
to methyl phenyl tetrahydropyridine (MPTP), a drug used to 
model PD in experimental studies.(81) Furthermore, PGC-
1α protects against neuronal loss in cell culture models of 
PD.(82,83)
 PGC-1α has also been implicated in AD, ALS and 
Duchenne muscular dystrophy. Expression of PGC-1α is 
reduced in AD patients and in the transgenic 2576 mouse 
model of AD.(84-86) Importantly, ectopic expression of 
PGC-1α in cell models of AD ameliorates their phenotype.
(84,85) In ALS, it has been shown that PGC-1α improves 
the overall phenotype of various mouse models of ALS.
(86-88) Lastly, PGC-1α has been shown to regulate the 
expression of neuromuscular junction genes, such as 
utrophin and laminin, as well as decrease damage to muscle 
tissue in a mouse model of Duchenne muscular dystrophy.
(89) Overall, these data highlight a potential protective role 
for PGC-1α in different neurodegenerative conditions.
 Age-associated decrease in the respiratory chain 
capacity was reported in various tissues, such as skeletal 
muscle (90) and liver (91). Hypotheses were put forward 
that acquired mutations of mtDNA would increase with time 
and segregate in mitotic tissues to eventually cause decline 
of respiratory chain function leading to age-associated 
degenerative disease and ageing.(2,92)
Aging-associated decline is consistent across tissues, 
resulting in slower wound healing, reduced muscle mass 
and neurogenesis, hair loss, and changes in blood cell 
type distribution.(93) Tissue homeostasis and regeneration 
depends on resident progenitor cell function and availability, 
and is consistent with the observation that genetic depletion 
of tissue-speciic progenitors results in premature aging.
(17) Accumulation of genomic and mtDNA mutations 
place cellular functions at risk and are correlated with 
aging. Elevated mtDNA mutation rates decrease lifespan, 
impair stem cell self-renewal, and induce abnormal 
lineage differentiation during embryogenesis, which 
manifests as progeria and respiratory chain deiciency.
(15) Aging-associated signaling pathways can also induce 
mitochondrial dysfunction and increase generation of ROS 
that compromise stem cell proiciency, which can be blunted 
with the use of antioxidants.(17) The systemic environment 
also signiicantly impacts the function of resident stem cells, 
with muscle and liver cells rejuvenated to a more youthful 
state when exposed to a young environment, and young 
cells adopting an aged phenotype in response to an aged 
environment.(93,94)
 Metabolism supports fundamental processes 
throughout life, as cells require a continuous yet adaptable 
energy supply to meet the demands of their specialized 
functions. Metabolic lexibility fuels divergent stem cell 
fates, which include quiescence to minimize stress damage, 
proliferation and self-renewal to maintain progenitor pools, 
and lineage speciication for tissue regeneration. These 
vital processes are powered through the metabolism of 
energy substrates supplied by the environment, such as 
glucose, fatty acids, and amino acids.(95) Beyond providing 
energetic supply, metabolic circuits engage master genetic 
programs in control of cell behavior, with cellular identity 
and functional state relecting the speciic metabolic 
pathways being used.(95)
 Plasticity in energy metabolism allows stem cells to 
match the divergent demands of self-renewal and lineage 
speciication. Beyond a role in energetic support, new 
evidence implicates nutrient-responsive metabolites as 
mediators of crosstalk between metabolic lux, cellular 
signaling, and epigenetic regulation of cell fate. Stem cell 
metabolism also offers a potential target for controlling 
tissue homeostasis and regeneration in aging and disease.
(95)
 Embryonic stem cell (ESC)-based cardiac 
differentiation was used as a paradigm to ascertain the 
metabolic requirements for tissue speciication. Study by 
Chung ,et al., demonstrated that mitochondrial network 
maturation integrated with energy-consuming excitation-
contraction coupling is mandatory for securing functional 
progeny of a cardiac lineage. These indings contribute 
novel insight into the vital role of energetic circuits in 
genomic reprogramming during cardiac differentiation, 
establishing metabolic targets for directed cardiogenesis 
and regeneration.(96) Thus, the state of mitochondrial 
physiology is an important determinant of developmental 
competence inluencing the outcome of the differentiation 
process.(97)
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 Stimulation of mitochondria biogenesis can overcome 
the differentiation block in fast-dividing cells, while 
reducing mitochondrial content perturbs cardiomyocyte 
differentiation in slow-dividing cells.(98) Mitochondrial 
and metabolic infrastructure thus prime stem cells for 
differentiation. When induced to differentiate, ESC and 
mesenchymal stem cell (MSC) downregulate stemness 
genes and stimulate mtDNA replication in support of 
mitochondrial biogenesis and maturation of extensive 
and interconnected networks of elongated and cristae-rich 
mitochondria.(96,76,99-101) In parallel, upregulation of 
tricarboxylic acid (TCA) cycle enzymes and ETC subunits, 
and downregulation of glycolysis, increases mitochondrial 
capacity, enabling accelerated respiration and more eficient 
ATP production.(96,102) Transition from glycolysis to 
mitochondrial oxidative metabolism and maintenance of 
mitochondrial electron transport function is critical for 
differentiation.
 Nutrient-sensitive signaling pathways that regulate 
lifespan and energy metabolism, such as those mediated 
by AMP-activated protein kinase (AMPK), forkhead box 
O (FOXO), insulin/IGF-1, and Mammalian Target of 
Rapamycin (mTOR), impact stem cell function. (103,104) 
Stemness is maintained in response to signals of plenty 
(insulin signaling and abundant amino acids), while signal 
reduction during starvation induces differentiation.(105) 
Inhibition of mTOR with rapamycin extends lifespan 
of mice and restores self-renewal and hematopoiesis of 
Figure 4. Metabolic Pathways for 
Stemness Maintenance. Catabolic and 
anabolic pathways are interconnected to 
provide stem cells suficient energy for 
homeostasis while producing requisite 
macromolecules for daughter cell 
replication.(95) (Adapted with permission 
from Cell Press).
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aged hematopoietic stem cell (HSC).(106,107) Signaling 
pathways that regulate aging and stem cell function may 
collectively converge on energy metabolism, which 
functions as a rheostat to regulate self-renewal and 
differentiation.
 AMPK enhances situin (SIRT)1 activity by increasing 
cellular nicotinamide adenine dinucleotide (NAD)1 levels, 
resulting in the deacetylation and modulation of the activity 
of downstream SIRT1 targets that include the PGC-1α 
and the FOXO1 and FOXOγα transcription factors. The 
AMPK-induced SIRT1-mediated deacetylation of these 
targets explains many of the convergent biological effects 
of AMPK and SIRT1 on energy metabolism. AMPK is a 
critical regulator of mitochondrial biogenesis in response 
to energy deprivation. Although the mechanisms by which 
AMPK modulates mitochondrial gene expression are not 
entirely elucidated, they seem to require the PGC-1α, either 
by increasing its expression or direct phosphorylation. 
Because PGC-1α is also activated by SIRT1-mediated 
deacetylation, that AMPK alters PGC-1α activity by 
changing its acetylation status.(108-116)
 FOXOs are important in maintaining the long-term 
regenerative potential of the HSC compartment, and that 
analysis of the role of FOXOs in other adult stem cell and 
ESC compartments may yield insights into the physiology 
and diseases of the renewing organ systems of long-lived 
species, including humans.
 Senescence represents a stress response in which 
cells withdraw from the cell cycle and lose the capability 
to proliferate in response to growth factors or mitogens.
(117,118) Senescent cells show very distinctive changes 
in morphology, acquiring a typical lat and enlarged shape 
and increase expression of recognized biomarkers of 
senescence, including staining for ȕ-galactosidase at pH of 
6.0 (senescence-associated-ȕ-gal or SA-ȕ-gal), decreased 
replicative capacity, increased expression of p53, p21, p16.
 The constant regeneration of somatic tissues leads 
to accumulation of senescent cells, which limits tissue 
renewal, perturbs normal tissue homeostasis and ultimately 
elicits aging. The senescence pathway can be triggered by 
multiple mechanisms. Originally, it was associated with 
replication exhaustion at the end of the cellular lifespan, a 
process currently deined as replicative senescence.(119) 
p53 functions as a transcription factor involved in cell-cycle 
control, DNA repair, apoptosis and cellular stress responses. 
However, besides inducing cell growth arrest and apoptosis, 
p53 activation also modulates cellular senescence and 
organismal aging.(119)
 Genotoxic stress brought about by telomere attrition, 
impaired DNA repair, ultraviolet (UV) radiation, ionizing 
radiation (IR), chemicals, ROS and other mechanisms 
activates p53 and induces cellular growth arrest (in 
proliferating compartments), senescence or apoptosis. p53 
can impair mitochondrial function either directly or indirectly 
(through regulation of ROS-detoxifying enzymes). This 
p53-mediated mitochondrial dysfunction triggers a cycle of 
DNA damage, p53 activation, mitochondrial compromise 
and increased ROS levels leading to additional DNA damage, 
and so on. The mitochondrial compromise could contribute 
to organ dysfunction through decreased ATP generation, as 
well as changes in mitochondrial metabolism. The interplay 
between p53 and other pathways implicated in aging is also 
indicated. CR activates SIRT1, which decreases p53 activity. 
Also, SIRT1 (and possibly SIRT6) activates PGC-1α and 
boosts mitochondrial biogenesis.(1β0) PGC-1α increases 
antioxidant defence through upregulation of antioxidants 
(81), whereas p53 has been shown to increase or decrease 
the expression of antioxidants depending on cellular ROS 
concentrations (121). B-lymphoma Moloney murine 
leukemia virus insertion region-1 (Bmi1) loss has been 
shown to induce mitochondrial dysfunction directly and 
induce upregulation of p16/ARF.(1ββ,1βγ) ARF increases 
p53 activity through interaction with mouse double minute 
2 homolog (MDM2), the negative regulator of p53.(17)
  Applying regenerative metabolism principles to 
rejuvenate stem cell metabolism has the potential to 
deterministically alter the fate of differentiating tissues 
for improved function and repair capacity in aging and/
or disease. As a paradigm of metabolic repair, MSCs 
demonstrate a capacity to transfer mitochondria and rescue 
aerobic respiration in cells lacking mitochondria.(124) 
Mitochondrial transfer has also been observed during stem 
cell therapy following lung injury, resulting in elevated 
alveolar ATP levels, which contributes to protection 
and repair of pulmonary alveoli.(125) Next-generation 
regenerative platforms with optimized stem cell metabolism 
will thus be equipped to titrate metabolic competencies and 
accordingly regenerate tissues and organs.
 CR boosts the number and myogenic function 
of skeletal muscle stem cells, which is associated with 
the expression of the metabolic regulators SIRT1 and 
FOXOγα, mitochondrial biogenesis, and enhanced 
oxidative metabolism at the expense of glycolysis.(126) 
The way stem cells use energy and intermediate metabolites 
determines their prospects. Metabolic regimes shape self-
renewal proiciency, and fuel interconversion of versatile 
lineage identities. The orchestrated commissioning and 
decommissioning of metabolic pathways enables stem 
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cell differentiation, and also supports reacquisition of 
pluripotency.(95)
 SIRTs are a highly conserved family of NAD1-
dependent enzymes that regulate lifespan in lower organisms. 
Recently, the mammalian SIRTs have been connected to an 
ever widening circle of activities that encompass cellular 
stress resistance, genomic stability, tumorigenesis and 
energy metabolism.
 SIRT1 through its regulation of PPAR-Ȗ and PGC-1α 
activity has a signiicant regulatory role in fat mobilization 
and FAO.(1β8,1β9) The regulation of PGC-1α activity 
also suggests a role for SIRT  in the generation of new 
mitochondria, as PGC-1α is a key regulator of mitochondrial 
biogenesis. These observations, coupled with recent links 
between SIRT1 and autophagy (130), suggest that SIRT might 
regulate the lux of mitochondria within cells by balancing 
PGC-1α mediated generation with autophagy-dependent 
Figure 5. A model of interaction between DNA damage, p53 activation 
and mitochondrial dysfunction.(17) (Adapted with permission from Nature 
Publishing Group).
clearance. In addition to the connection between SIRT1 and 
the mitochondria, SIRT3-dependent deacetylation regulates 
the activity of the mitochondrial enzyme acetyl coenzyme 
A synthetase 2 (AceCS2) (131,132) as well as Complex I 
of ETC. Mitochondrial lysates from SIRT3-/- mice reveal 
>30 proteins whose acetylation is markedly increased, 
suggesting that other important targets undoubtedly exist.
(133,134) Finally, a very recent study has implicated SIRT5, 
another mitochondrial SIRT, as an important regulator of 
the urea cycle.(135)
 In mice treatment with resveratrol, 
(3,5,4’-trihydroxystil- bene), a diet-derived polyphenol, 
improved mitochondrial function and biogenesis in the 
skeletal muscle (114) and the liver (136). Studies in diabetic 
mice demonstrated that resveratrol treatment improves 
endothelial function and attenuates vascular inlammation 
in diabetes mellitus (137-141) and extends longevity 
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Recent data suggest that we age, in part, because our self-
renewing stem cells grow old as a result of heritable intrinsic 
events, such as DNA damage, as well as extrinsic forces, 
such as changes in their supporting niches. Mechanisms 
that suppress the development of cancer, such as senescence 
and apoptosis, which rely on telomere shortening and 
the activities of p53 and p16INK4a, may also induce an 
unwanted consequence: a decline in the replicative function 
of certain stem-cell types with advancing age.
 Age-associated telomere damage, diminution of 
telomere ‘capping’ function and associated p53 activation 
have emerged as prime instigators of a functional decline 
of tissue stem cells and of mitochondrial dysfunction that 
adversely affect renewal and bioenergetic support in diverse 
tissues. Constructing a model of how telomeres, stem cells 
and mitochondria interact with key molecules governing 
genome integrity, ‘stemness’ and metabolism provides a 
framework for how diverse factors contribute to aging and 
age-related disorders.
 The need to develop therapeutic strategies to 
treat pathophysiological conditions in the elderly is 
therefore medically, socially, and economically crucial. 
Characterization of normal stem cell aging is the critical irst 
step toward achieving these goals as such research should 
be able to identify the mechanisms underlying stem cell 
functional decline and inform strategies for intervention.
Conclusion
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